Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

SMMT Q3 2020 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$181,000

Gross Profit

$181,000100.0% margin

Operating Income

-$17M-9359.7% margin

Net Income

-$18M-9779.6% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$361,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$20M

Stockholders' Equity

$37M

Cash & Equivalents

$21M

Revenue Segments

License and Service

$181,000100%

Geographic Segments

Latin America

$181,000100%

← FY 2020 All Quarters Q4 2020 →